Status:

RECRUITING

Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study

Lead Sponsor:

University of Zurich

Collaborating Sponsors:

Center for Proton Therapy, Paul Scherrer Institute, Villigen,Switzerland

GratXray AG

Conditions:

Breast Cancer

Microcalcification

Eligibility:

All Genders

18+ years

Brief Summary

Conventional mammography, breast sonography and breast MRI have specific weaknesses. In particular, mammography has a low sensitivity for the detection of mammary carcinoma in patients with a dense br...

Detailed Description

Category C2 Medicine product without CE label. Objective(s): Phase 0: Imaging of mastectomy and breast biopsy samples to validate the image quality and radiation dose. Phase 1: Determination of accu...

Eligibility Criteria

Inclusion

  • Inclusion criteria -Phase 0:
  • \>18 years
  • Mastectomy, tumorectomy or biopsy planned
  • Informed consent of the patient
  • Inclusion criteria -Phase 1:
  • \>18 years
  • BI-RADS 5 (highly suggestive of malignancy at ultrasound or mammography) or 6 (known biopsy proven malignancy);
  • Scheduled for mastectomy or breast conserving surgery with radiotherapy.
  • Informed consent of the patient
  • Inclusion criteria - Phase 2:
  • \>40 years
  • undergoing mammography for screening or diagnostic purpose.
  • Informed consent of the patient

Exclusion

  • Exclusion criteria for all three Phases:
  • Breast implants. The women will be asked, if they have a breast-implant.
  • Inability to understand the study procedure due to cognitive or linguistic deficits.
  • Exclusion criteria for patients, participating in Phase 1 and Phase 2:
  • Pregnancy
  • Breast-feeding.
  • Re-staging after neoadjuvant chemotherapy. Patients who participated in prior research projects with ionizing radiation in the past 12 months

Key Trial Info

Start Date :

October 17 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2030

Estimated Enrollment :

350 Patients enrolled

Trial Details

Trial ID

NCT06489665

Start Date

October 17 2024

End Date

September 1 2030

Last Update

February 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Hospital Zurich - Diagnostic Radiology

Zurich, Canton of Zurich, Switzerland, 8091

2

University of Zurich

Zurich, Switzerland